GGrantIndex
Sort

82,697 grants matching vaccine development

Western States Node of the National Drug Abuse Treatment Clinical Trials Network

$870,391
James L. Sorensen · University Of California, San Francisco · UG1 · FY2015 · DA

Genetic, structural and functional profiling of the human antibody response to arenavirus infection

$870,348
Bryan Briney · Scripps Research Institute, The · R01 · FY2023 · AI

Mechanisms of mucosal protection induced by attenuated SIV

$870,309
R. Paul Johnson · Harvard Medical School · P01 · FY2008 · AI

Preclinical Development of PS-26 - an Oxybiguanide

$870,251
Jacobus Pharmaceutical Company, Inc. · R44 · FY2002 · AI

Signal Transduction Events and the Regulation of Cell Growth

$870,159
Jane B Trepel · Division Of Clinical Sciences - Nci · ZIC · FY2016 · CA

Project 3 - Dynamics of latent HIV-1 reservoirs: High resolution antigenic mapping and strategies to block rebound

$870,076
Priyamvada Acharya · Duke University · U54 · FY2022 · AI

Scanning the F. tularensis Proteome for Vaccine Antigens

$870,020
University Of California Irvine · U01 · FY2004 · AI

Immune Control and Evasion during Acute HCV Infection

$869,999
Massachusetts General Hospital · U19 · FY2005 · AI

INNATE IMMUNE RESPPONSE TO MICROBIAL INFECTION

$869,903
University Of Iowa · P01 · FY2000 · AI

Balancing epithelial cell resistance and resilience to respiratory viral infections

$869,852
Jose Manuel Ordovas-Montanes · Boston Children'S Hospital · R01 · FY2023 · HL

Maximizing germinal centers and somatic hypermutation to HIV Env immunogens

$869,654
Shane P Crotty · La Jolla Institute For Immunology · R37 · FY2023 · AI

The FIOCRUZ Therapeutic and Prevention HIV/AIDS Clinical Trials Unit.

$869,573
Beatriz Grinsztejn · Fundacao Oswaldo Cruz · UM1 · FY2025 · AI

Sexual Development of Cryptosporidium

$869,492
Boris Striepen · University Of Pennsylvania · R01 · FY2025 · AI

Alloantigen Delivery Via ECDI-Fixed Cells For Tolerance To Monkey Islet Grafts

$869,444
Bernhard Josef Hering · University Of Minnesota · U01 · FY2016 · AI

Alloantigen Delivery Via ECDI-Fixed Cells For Tolerance To Monkey Islet Grafts

$869,444
Bernhard Josef Hering · University Of Minnesota · U01 · FY2012 · AI

Alloantigen Delivery Via ECDI-Fixed Cells For Tolerance To Monkey Islet Grafts

$869,444
Bernhard Josef Hering · University Of Minnesota · U01 · FY2014 · AI

Development of Aersolized Vaccines

$869,351
Mario Roederer · National Institute Of Allergy And Infectious Diseases · ZIA · FY2011 · AI

Novel Adjuvant Discovery in Vaccine Therapy

$869,286
Jason S Lewis · Sloan-Kettering Inst Can Research · R01 · FY2011 · AI

Human Genetic Dissection of Exit from Latency in Tuberculosis

$869,244
Jean-Laurent Casanova · Weill Medical Coll Of Cornell Univ · U19 · FY2016 · AI

Understanding the functional role of Myeloid Derived Suppressor cells in tuberculosis

$869,240
Shabaana A. Khader · Washington University · R01 · FY2022 · AI

R5 SHIV/Macaque Models for the Evaluation of T and B Cell-Based HIV-1 Vaccines

$869,155
Cecilia C Cheng-Mayer · Aaron Diamond Aids Research Center · R01 · FY2010 · AI

Discovery and development of broad spectrum anti-flaviviral drugs

$869,118
Mariano A. Garcia-Blanco · Duke University · R01 · FY2010 · AI

TULANE/LSU PEDIATRIC AIDS CLINICAL TRIALS UNIT

$869,072
Tulane University Of Louisiana · U01 · FY2000 · AI

Therapeutic peanut allergen Fc gamma chimeric proteins to treat peanut allergy

$868,840
Nolan Sigal · Tunitas Therapeutics, Inc. · R42 · FY2012 · AI

The Role Of Innate Immunity Genes In Viral Infection and Disease Progression

$868,687
Steven R Kleeberger · National Institute Of Environmental Health Sciences · ZIA · FY2010 · ES